ResMed (RMD) Financials: Revenue & Earnings
RMD$252.19+2.02 +0.81%
$35.47B
Market Cap
23.96
P/E
20.85
Forward P/E
57
Score
ResMed (RMD) Financials: Revenue & Earnings
RMD price $252.19 +2.02 +0.81%
- Ticker
- RMD
- Price
- $252.19
- Change
- +2.02 +0.81%
- Market cap ?
- $35.47B
- P/E ?
- 23.96
- Forward P/E ?
- 20.85
- Dividend yield ?
- 0.98%
- Beta ?
- 0.75
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Stocklytics score
- 57
- Value
- 41
- Quality
- 86
- Growth
- 43
Stocklytics score rationale: value 41, quality 86, growth 43.
Financials
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 2066737000 | 2340196000 | 2606572000 | 2957013000 | 3196825000 | 3578127000 | 4222993000 | 4685297000 | 5146327000 | 5653443000 |
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies…
Earnings and financials
ResMed Inc. (RMD) trades at $252.19, with a market cap of $35.47B and a trailing P/E of 23.96. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 2066737000 | 2340196000 | 2606572000 | 2957013000 | 3196825000 | 3578127000 | 4222993000 | 4685297000 | 5146327000 | 5653443000 |
Insights · Dividends · Forecast · Financials · Learn